stockrowStevanato Group S.p.A.
STVN Healthcare Medical Instruments & Supplies
Stevanato Group S.p.A.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 12.3% from fiscal 2024.
- Revenue
- +5.91%
- EPS
- +17.5%
- Free cash flow
- +4,089.9%
- Total debt
- +2.85%
Quarter to September 2026, against a year earlier
Follow STVN
Alert me
Stevanato Group S.p.A. (STVN) Shares outstanding
Stevanato Group S.p.A.'s shares outstanding at the end of fiscal 2025 was $273.0M, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $273.1M. Over the past ten years it has ranged from $240.5M (fiscal 2020) to $273.0M (fiscal 2025) — the current reading is the highest in ten years. Stevanato Group S.p.A. ranks 9th of 47 Medical Instruments & Supplies companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $273.0M | 0.67% |
| FY2024 | $271.2M | 2.33% |
| FY2023 | $265.0M | 0.10% |
| FY2022 | $264.7M | 4.75% |
| FY2021 | $252.7M | 5.07% |
| FY2020 | $240.5M | (9.24%) |
| FY2019 | $265.0M | — |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $273.1M | 0.04% |
| Jun 2026 | $273.0M | 0.01% |
| Mar 2026 | $273.0M | 0.02% |
| Dec 2025 | $273.0M | (0.01%) |
| 22 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| MMED MiniMed Group, Inc. compare | $281.0M |
| STVN Stevanato Group S.p.A. | $273.1M |
| NVST Envista Holdings Corporation compare | $163.4M |
| WRBY Warby Parker Inc. compare | $126.1M |
| PLSE Pulse Biosciences, Inc compare | $71.9M |
| MMSI Merit Medical Systems, Inc. compare | $60.4M |
| ATRC AtriCure, Inc. compare | $49.8M |
| TFX Teleflex Incorporated compare | $43.7M |
| ICUI ICU Medical, Inc. compare | $25.1M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on STVN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement